Monoclonal anti-glycosphingolipid antibodies.
Kannagi
R
R
Program of Experimental Pathology, Aichi Cancer Center, Nagoya, Japan.
D000818:Animals; D000911:Antibodies, Monoclonal; D015295:Antigens, Tumor-Associated, Carbohydrate; D002051:Burkitt Lymphoma; D002855:Chromatography, Thin Layer / Q000379:methods; D006017:Glycolipids / Q000032:analysis / Q000276:immunology; D006028:Glycosphingolipids / Q000032:analysis* / Q000276:immunology / Q000302:isolation & purification; D006801:Humans; D006825:Hybridomas; D015151:Immunoblotting / Q000379:methods; D007075:Immunoglobulin M; D007158:Immunologic Techniques; D051379:Mice; D051381:Rats; D012475:Salmonella / Q000276:immunology; D055746:Stage-Specific Embryonic Antigens; D014407:Tumor Cells, Cultured
D000911:Antibodies, Monoclonal; D015295:Antigens, Tumor-Associated, Carbohydrate; D006017:Glycolipids; D006028:Glycosphingolipids; D007075:Immunoglobulin M; D055746:Stage-Specific Embryonic Antigens; C052924:stage-specific embryonic antigen-3; C414128:techneticum TC-99M fanolesomab